ダウンロード数: 77

このアイテムのファイル:
ファイル 記述 サイズフォーマット 
69_6_169.pdf687.68 kBAdobe PDF見る/開く
タイトル: 繰り返す術後出血を契機に診断された自己免疫性後天性凝固第13因子(FXIII)欠乏症の1例
その他のタイトル: A Case of Autoimmune Acquired Factor XIII Deficiency Diagnosed from Recurrent Postoperative Bleeding
著者: 髙島, 靖  KAKEN_name
川西, 博晃  KAKEN_name
小谷, 槙一  KAKEN_name
渡邊, 拓樹  KAKEN_name
横関, 仁志  KAKEN_name
舟橋, 優里奈  KAKEN_name
髙岡, 直澄  KAKEN_name
藤原, 真希  KAKEN_name
奥村, 和弘  KAKEN_name
著者名の別形: TAKASHIMA, Yasushi
KAWANISHI, Hiroaki
KOTANI, Shinichi
WATANABE, Hiroki
YOKOZEKI, Hitoshi
FUNAHASHI, Yurina
TAKAOKA, Naoto
FUJIWARA, Maki
OKUMURA, Kazuhiro
キーワード: Autoimmune acquired factor XIII deficiency
Postoperative bleeding
発行日: 30-Jun-2023
出版者: 泌尿器科紀要刊行会
誌名: 泌尿器科紀要
巻: 69
号: 6
開始ページ: 169
終了ページ: 173
抄録: The patient was a 79-year-old man with ureteroileal anastomotic stricture after a Bricker ileal conduit. Endourological treatment of stenosis was performed via percutaneous nephrostomy and ileal conduit. The patient experienced lower abdominal pain on the following day, and computed tomographic (CT) scan showed hematoma retention around the kidney and active bleeding from the renal artery branches. Transarterial embolisation (TAE) was performed and the bleeding was controlled. Two days later, there was a sudden progression of anemia and CT showed an increase in hematoma around the kidney. We subsequently performed nephrectomy for hemostasis. Five days later, the anemia progressed further. There was hematoma retention in the retroperitoneal cavity, and emergency laparotomy hemostasis was performed. Routine coagulation test results were normal. Heavy bleeding was observed several days after TAE and the possibility of coagulation factor XIII deficiency was considered. Factor XIII deficiency was confirmed by a low factor XIII activity level. The patient was given plasma-derived factor XIII. After receiving factor XIII replacement, factor XIII activity remained unchanged and the patient continued to bleed. Thereafter, a cross-mixing test was performed and the patient was diagnosed with autoimmune acquired factor XIII deficiency. Cortical steroids were administered to remove the factor XIII inhibitor. Steroid administration showed a rapid increase in factor XIII activity, and bleeding symptoms were no longer observed. In cases of serious bleeding of unknown cause with a normal coagulation profile, acquired factor XIII deficiency should be suspected and factor XIII activity measured.
著作権等: 許諾条件により本文は2024-07-01に公開
DOI: 10.14989/ActaUrolJap_69_6_169
URI: http://hdl.handle.net/2433/284405
PubMed ID: 37460281
出現コレクション:Vol.69 No.6

アイテムの詳細レコードを表示する

Export to RefWorks


出力フォーマット 


このリポジトリに保管されているアイテムはすべて著作権により保護されています。